117 related articles for article (PubMed ID: 21172589)
21. Regarding "in situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998)".
Calligaro KD
J Vasc Surg; 2000 Apr; 31(4):837-8. PubMed ID: 10753300
[No Abstract] [Full Text] [Related]
22. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
23. Prevention of early graft infection with rifampicin-bonded Gelseal grafts: a multicentre experimental study.
D'Addato M; Curti T; Freyrie A; Agus GB; Bertini D; Biasi G
Cardiovasc Surg; 1994 Apr; 2(2):254-8. PubMed ID: 8049957
[TBL] [Abstract][Full Text] [Related]
24. Commentary on ''Microbial spectrum and primary resistance to rifampicin in infectious complications in vascular surgery: limits to the use of rifampicin-bonded prosthetic grafts''.
Naylor AR
Angiology; 2010 Jul; 61(5):421-2. PubMed ID: 20581199
[No Abstract] [Full Text] [Related]
25. The effect of antimicrobial impregnation on vascular graft healing. An experimental porcine study.
Pärsson H; Jundzill W; Hallberg E; Norgren L
Vasa; 1992; 21(4):355-9. PubMed ID: 1485468
[TBL] [Abstract][Full Text] [Related]
26. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination.
Schmacht D; Armstrong P; Johnson B; Pierre K; Back M; Honeyman A; Cuthbertson D; Bandyk D
Vasc Endovascular Surg; 2005; 39(5):411-20. PubMed ID: 16193213
[TBL] [Abstract][Full Text] [Related]
27. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
28. Re: Efficacy of silver in preventing bacterial infection of vascular dacron graft material.
O'Connor SA
Eur J Vasc Endovasc Surg; 2004 May; 27(5):565. PubMed ID: 15080881
[No Abstract] [Full Text] [Related]
29. [Biomaterials and tissues material in the treatment of prosthetic grafts infections].
Pupka A; Abrahamów A; Szyber P
Polim Med; 2005; 35(2):41-7. PubMed ID: 16218131
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic-coated ePTFE decreases graft colonization and neointimal hyperplasia.
Fischer PE; Schroeppel TJ; Fabian TC; deRijk WG; Edwards NM; Magnotti LJ; Doty DH; Croce MA
J Surg Res; 2009 Oct; 156(2):199-204. PubMed ID: 19481768
[TBL] [Abstract][Full Text] [Related]
31. Early host tissue response to different types of vascular prostheses coated with silver acetate or vaporized metallic silver.
Jeanmonod P; Laschke MW; Gola N; von Heesen M; Glanemann M; Menger MD; Moussavian MR
Eur J Vasc Endovasc Surg; 2014 Jun; 47(6):680-8. PubMed ID: 24726145
[TBL] [Abstract][Full Text] [Related]
32. [Experimental study on the prevention of vascular prosthetic infection with an antibiotic-bonded dacron graft].
Yu WP; Jing ZP; Bao JM; Zhao ZQ; Zhao J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):348-9. PubMed ID: 15854516
[No Abstract] [Full Text] [Related]
33. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections.
Bandyk DF; Novotney ML; Johnson BL; Back MR; Roth SR
J Surg Res; 2001 Jan; 95(1):44-9. PubMed ID: 11120634
[TBL] [Abstract][Full Text] [Related]
34. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings.
Darouiche RO; Meade R; Mansouri M; Raad II
J Heart Valve Dis; 1998 Nov; 7(6):639-46. PubMed ID: 9870198
[TBL] [Abstract][Full Text] [Related]
35. In-vitro and in-vivo activity of antimicrobial-coated prosthetic heart valve sewing cuffs.
Darouiche RO; Mansouri MD; Meade R
J Heart Valve Dis; 2002 Jan; 11(1):99-104. PubMed ID: 11843512
[TBL] [Abstract][Full Text] [Related]
36. Healing of implanted expanded polytetrafluoroethylene vascular access grafts with different internodal distances: a histologic study in dogs.
Kuzuya A; Matsushita M; Oda K; Kobayashi M; Nishikimi N; Sakurai T; Komori K
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):404-9. PubMed ID: 15350564
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity and in vivo efficacy of antimicrobial-coated vascular grafts.
Darouiche RO; Mansouri MD
Ann Vasc Surg; 2004 Jul; 18(4):497-501. PubMed ID: 15156366
[TBL] [Abstract][Full Text] [Related]
38. Major groin complications following the use of synthetic grafts.
Exton RJ; Galland RB
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):188-90. PubMed ID: 17512763
[TBL] [Abstract][Full Text] [Related]
39. Results from the first in man german pilot study of the silver graft, a vascular graft impregnated with metallic silver.
Zegelman M; Guenther G; Florek HJ; Orend KH; Zuehlke H; Liewald F; Storck M
Vascular; 2009; 17(4):190-6. PubMed ID: 19698298
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional network-structured film coating for woven and knitted polyethylene terephthalate against cardiovascular graft-associated infections.
Al Meslmani BM; Mahmoud GF; Sommer FO; Lohoff MD; Bakowsky U
Int J Pharm; 2015 May; 485(1-2):270-6. PubMed ID: 25796119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
